Moderna's coronavirus vaccine just showed early signs of success in an early study in people
A pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19.Moderna released the first human results from its coronavirus vaccine candidate on Monday.
The Massachusetts biotech described Monday the immune system responses to the vaccine from this first, small study that was primarily focused on safety. The results don't yet show whether the vaccine would prevent people from being infected with the novel coronavirus. All participants developed detectable antibodies, and Moderna said there were "dose dependent increases in immunogenicity" across the three potencies.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Trump launches 'operation warp speed' effort to develop coronavirus vaccine by year's endPresident Trump has launched a new initiative, nicknamed 'Operation Warp Speed' to find a coronavirus vaccine.
Read more »
Public health official: widespread coronavirus vaccine likely for 2021 - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »
Latest on global search for coronavirus vaccine: Oxford vaccine may protect monkeys from COVIDA single dose of a vaccine being developed by Oxford University in England caused rhesus macaque monkeys to develop antibodies to coronavirus within 28 days.
Read more »
U.K. 'COVID Dogs' to Cost $600,000 in trial research aimed at sniffing out coronavirus in humansOfficials hope the specially trained dogs could could sniff out up to 250 people an hour for coronavirus before symptoms emerge.
Read more »
Coronavirus Vaccine Frontrunners Emerge, Rollouts WeighedGovernments and drugmakers weigh how to roll out coronavirus vaccines when they become available, including reserving first batches for health-care workers, as several shots race to be ready in late 2020.
Read more »